Drug Shortage Report for TARO-PEMETREXED
Report ID | 167886 |
Drug Identification Number | 02429209 |
Brand name | TARO-PEMETREXED |
Common or Proper name | PEMETREXED |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | PEMETREXED |
Strength(s) | 500MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 500MG/20ML |
ATC code | L01BA |
ATC description | ANTIMETABOLITES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-07-12 |
Estimated end date | 2022-09-30 |
Actual end date | 2022-10-13 |
Shortage status | Resolved |
Updated date | 2022-11-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-11-03 | French | Compare |
v5 | 2022-11-03 | English | Compare |
v4 | 2022-09-16 | French | Compare |
v3 | 2022-09-16 | English | Compare |
v2 | 2022-08-25 | French | Compare |
v1 | 2022-08-25 | English | Compare |
Showing 1 to 6 of 6